Resources
Filter by Topic
- Infographic
For a more comprehensive view of the patient journey and experience, life sciences organizations must turn data into insights. Panalgo’s Instant Health Data (IHD) platform...
- Case Study
In this case study, we dive into how this company educated employees in data science analytics techniques across departments with various skillsets and fostered a...
- Blogs
Today’s life sciences companies need efficient ways to turn real-world data into meaningful insights. To explore how Panalgo’s Instant Health Data (IHD) and IHD Cloud...
- Case Study
With Panalgo’s IHD, a company successfully accelerated its ability to derive actionable insights from real-world data, leading to tangible business benefits.
- Press Releases
Global provider of pharma intelligence solutions joins the ranks of Waymo, Nvidia, Duolingo, and more
- Case Study
A biopharma manufacturer developing a rare disease treatment needed to quantify its potential patient population.
- Case Study
When a medical device company was preparing to launch a new product, it turned to Panalgo to generate robust data for an HEOR study on...
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
September 28, 2021, Yardley, PA – Managed Markets Insight & Technology (MMIT) and Evaluate (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined
RWE: Supporting Regulatory Submissions with Real-World Evidence
In this article with HIT Consultant, Tiffany Siu Woodworth, Director of Analytics Solutions at Panalgo, discusses RWE within the regulatory landscape. She notes how in
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model
Click here for the publication.
Podium and Posters from ICPE 2021
PODIUM PRESENTATION: Predictors of Severe COVID-19 Outcomes in Patients with Rheumatoid Arthritis Presented by Sara Burns SPOTLIGHT POSTER: Factors Associated with Initiation of Oral vs.
Leveraging RWD in Observational Studies: Understanding the Implications of Time-Related Biases
Dr. Suissa spoke at Panalgo’s 2021 IHD User conference about the implications of relying on observational studies that may have time-related biases and how to
Innovating RWE Organizations: Learning from the Past and Looking to the Future
Chris spoke at Panalgo’s 2021 IHD User conference about the evolution of Real-World Evidence (RWE) and how pharma needs to reimagine its function – to
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization